Stock Track | Prestige Consumer Healthcare Plunges 6.39% After-Hours on Earnings Miss and Weak Guidance

Stock Track

May 14

Prestige Consumer Healthcare's stock experienced a significant after-hours plunge of 6.39% on Wednesday following the release of its fiscal fourth-quarter and full-year results.

The consumer healthcare company reported adjusted earnings of $1.23 per share for the quarter, missing the analyst consensus estimate of $1.39. Quarterly revenue of $281.6 million also fell short of the expected $293.6 million. For the full fiscal year 2026, revenue declined 4.3% to $1.09 billion, while earnings per share dropped to $3.91 from $4.29 a year earlier.

The company cited several factors for the weaker performance, including supply constraints in its Eye & Ear Care category that limited its ability to meet demand for Clear Eyes products. International segment revenue was hurt by shipping disruptions in the Middle East, and accelerated order timing in the prior year created a headwind for the current quarter. Furthermore, the company's fiscal 2027 guidance for revenue and adjusted earnings per share came in below analyst expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1176310401"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176310401\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176310401?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 06:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176310401","market":"nz","top_or_hot":-1,"title":"Stock Track | Prestige Consumer Healthcare Plunges 6.39% After-Hours on Earnings Miss and Weak Guidance","media":"Stock Track","content":"<p>Prestige Consumer Healthcare's stock experienced a significant after-hours plunge of 6.39% on Wednesday following the release of its fiscal fourth-quarter and full-year results.</p><p>The consumer healthcare company reported adjusted earnings of $1.23 per share for the quarter, missing the analyst consensus estimate of $1.39. Quarterly revenue of $281.6 million also fell short of the expected $293.6 million. For the full fiscal year 2026, revenue declined 4.3% to $1.09 billion, while earnings per share dropped to $3.91 from $4.29 a year earlier.</p><p>The company cited several factors for the weaker performance, including supply constraints in its Eye & Ear Care category that limited its ability to meet demand for Clear Eyes products. International segment revenue was hurt by shipping disruptions in the Middle East, and accelerated order timing in the prior year created a headwind for the current quarter. Furthermore, the company's fiscal 2027 guidance for revenue and adjusted earnings per share came in below analyst expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Prestige Consumer Healthcare Plunges 6.39% After-Hours on Earnings Miss and Weak Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Prestige Consumer Healthcare Plunges 6.39% After-Hours on Earnings Miss and Weak Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-14 06:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Prestige Consumer Healthcare's stock experienced a significant after-hours plunge of 6.39% on Wednesday following the release of its fiscal fourth-quarter and full-year results.</p><p>The consumer healthcare company reported adjusted earnings of $1.23 per share for the quarter, missing the analyst consensus estimate of $1.39. Quarterly revenue of $281.6 million also fell short of the expected $293.6 million. For the full fiscal year 2026, revenue declined 4.3% to $1.09 billion, while earnings per share dropped to $3.91 from $4.29 a year earlier.</p><p>The company cited several factors for the weaker performance, including supply constraints in its Eye & Ear Care category that limited its ability to meet demand for Clear Eyes products. International segment revenue was hurt by shipping disruptions in the Middle East, and accelerated order timing in the prior year created a headwind for the current quarter. Furthermore, the company's fiscal 2027 guidance for revenue and adjusted earnings per share came in below analyst expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PBH","symbol_name":"普雷斯蒂奇","start_time":0,"source_url":"","article_id":"1176310401","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176310401","pubTimestamp":1778711024,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Prestige Consumer Healthcare's stock experienced a significant after-hours plunge of 6.39% on Wednesday following the release of its fiscal fourth-quarter and full-year results.The consumer...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PBH":"普雷斯蒂奇"},"translate_title":"个股追踪|Prestige Consumer Healthcare盘后暴跌6.39%，因盈利未达预期和指引疲弱","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBH":1},"content_text":"Prestige Consumer Healthcare's stock experienced a significant after-hours plunge of 6.39% on Wednesday following the release of its fiscal fourth-quarter and full-year results.The consumer healthcare company reported adjusted earnings of $1.23 per share for the quarter, missing the analyst consensus estimate of $1.39. Quarterly revenue of $281.6 million also fell short of the expected $293.6 million. For the full fiscal year 2026, revenue declined 4.3% to $1.09 billion, while earnings per share dropped to $3.91 from $4.29 a year earlier.The company cited several factors for the weaker performance, including supply constraints in its Eye & Ear Care category that limited its ability to meet demand for Clear Eyes products. International segment revenue was hurt by shipping disruptions in the Middle East, and accelerated order timing in the prior year created a headwind for the current quarter. Furthermore, the company's fiscal 2027 guidance for revenue and adjusted earnings per share came in below analyst expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}